Title: Liza Leventhal, et al. Phosphodiesterase 9 inhibitor and levodopa therapy. WO 2017070293 A1.
1105198-46-6
307341-29-3
1429232-68-7
1429233-51-1
1252608-59-5 | Gibh-130 | AA01EOHP | MFCD31544336
2057509-72-3 | AZD4573 | AA01EONB
1427325-88-9 | 1-(1-pentyl-1H-indol-3-yl)-2-(m-tolyl)ethanone | AA01EOUL
1185282-19-2 | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(3-fluorophenyl)methyl]-1H-indazole-3-carboxamide | AA01EP3M
13616-29-0 | 4,4'-(Carbonylbis(azanediyl))bis(N-(4-methylpyrimidin-2-yl)benzenesulfonamide) | AA01EPD6 | MFCD11114386
62600-81-1 | (1R)-1-[[(1-oxohexadecyl)oxy]methyl]-2-(phosphonooxy)-9Z-octadecenoicacidethylester | AA01EPJH
1465-22-1 | N-(3-methylphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide,monohydrochloride | AA01EPPH
93138-53-5 | 2-methyl-1-(phenylmethyl)-piperazine,dihydrochloride | AA01EPW6 | MFCD02671087
1082721-49-0 | N-[1-[2-(3-methylphenyl)ethyl]-4-piperidinyl]-N-phenyl-propanamide,monohydrochloride | AA01EQ5Q
949588-40-3 | ORG25935-SCH900435 | AA01EQC2 | MFCD19708017